ایRam Verma, a cleaner, breathed a sigh of relief as he joined the Holy Family Hospital in New Delhi. As the first person to receive a corona virus vaccine in India on Saturday. It marks the launch of the world’s largest vaccination program. She was feeling a little unwell.
“I have to admit I was nervous,” Verma said. , Who received his covacine jaw at a center in the hospital’s car park. “There were a lot of us. I thought I might faint or it would have side effects. Anyway, that’s a whole new thing. But I’m fine. No worries.
Anila Singh, a nurse at the capital’s Ram Manohar Lohia Hospital, said she was almost relieved when she heard that she was in the first group to receive the vaccine. “I thought about all the people I saw dying, all the families who had lost a loved one and out of their own fear of catching the virus, all this,” he said. Come back. ” “Finally we are going to change the page.”
Across India, 3,006 vaccination centers undertook the massive task of vaccinating 300 million people by August, with healthcare workers, police and army members given first priority. India ranks second in the world in terms of Kwid 19, with more than 10.5 million deaths and more than 151,000 deaths.
Two vaccines have been given emergency approval for India’s immunization program: the Oxford / AstraZeneca vaccine, known as CoveShield in India, and the Indian pharmaceutical company Bharat Biotech in collaboration with the Government of Indian Medical Research Council. A home-made product, the Oxford / AstraZeneca vaccine. Body.
While it was a slow start on Saturday, the pressure was on to pick up the pace. Within a week, Mumbai plans to vaccinate 50,000 people a day, an even higher number in Delhi. “Once there are a thousand vaccination centers in our city, we will vaccinate 100,000 a day,” said Dr Sanila Garg, head of the vaccination task force in Delhi.
Announcing the launch of the vaccine program as a moment of reflection for India, Prime Minister Narendra Modi said, “It shows the world our potential.” Doctors, health rights advocates and scientists have questioned Kovacson’s eligibility and safety, accusing the government of moving toward protocols for its approval.
The vaccine has not been able to complete Phase 3 human trials and there are no conclusive data on its efficacy, which has put India between Russia and China, which is still at a critical stage. Decided to make a vaccine. The government says Kovacin is “100% safe” and 5.5 million doses of it were shipped across the country on Saturday, although they will be given in “trial mode”.
On Saturday, the Association of Resident Physicians of Ram Manohar Lohia Hospital wrote a letter to the hospital superintendent expressing concern about Kovacson and requesting permission to have a cove shield instead.
Dr Nirmalia Mopatra, a senior resident doctor and vice-president of the association, said: “We are very concerned because we do not have the same data for Kovacson. That the vaccine does not protect us from another wave of infection as it is still being tested, so we are only asking for a choice as to which vaccine we are given.
Mahapatra said that without offering a choice, it could lead to widespread denial of vaccination among doctors. At Ram Manohar Lohia Hospital on Saturday, 31 out of 100 health workers registered for the vaccine, which was partly due to a technical glitch but also due to staff concerns that the hospital Offering only vaccines.
India Biotech has done the same Allegations of moral turpitude have been made The case was filed against people in the Bhopal slums in Madhya Pradesh for allegedly testing cocaine without informing them. Seven people claim to have been told they were taking a vaccine that would protect them from the virus, and they were paid Rs 750, without knowing it was an untested vaccine or maybe they had one. Placebo found.
In a letter to the government, several health rights organizations, including the All India Drug Action Network, the Forum for Medical Ethics Society and the People’s Health Movement India, have called for a halt to the covacon trial in Bhopal. “The testimonies show greed that represents a violation of the principles of voluntary participation,” he said. “Many participants were led astray to trial, their weaknesses were exposed.”
Bharat Biotech has denied any breach of ethics and said the lawsuit “complies with good guidelines of clinical practice and all regulatory provisions that apply to conducting clinical trials in India”.
Questions about the vaccine also did not help the government’s desperate efforts to combat the misinformation and fake rumors about the vaccine that are circulating on the WhatsApp and fueling hesitation. On Wednesday, Delhi Chief Minister Arvind Kejriwal had appealed to the people to be vigilant against misinformation about the vaccine.
Dr. Kali Dutta Das, a surgeon at the Center for Spinal Cord Injuries in New Delhi, said some fake rumors about the vaccine had caused last-minute unrest on Saturday. However, he remained encouraging. “We vaccinated 100 staff today and it was a very positive mood because people felt there was a solution in the end,” Das said.
STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ